Market Trends of Global HLA Typing Industry
This section covers the major market trends shaping the HLA Typing Market according to our research experts:
Hospital Segment is Expected to Exhibhit a Significant Market Growth in the HLA Typing Market
The hospital segment is expected to grow at a significant rate in the HLA typing market, due to the increasing number of organ transplants and the developing infrastructure of hospitals in terms of advanced devices and equipment. For instance, Cambridge University Hospital provides HLA typing tests for solid organ transplantation, hematopoietic stem cell transplantation, and also for the diagnosis of various diseases, such as rheumatoid arthritis, narcolepsy, and behçet's disease, among others.
Furthermore, according to organdonor.gov updated in March 2022, the number of organ donors and transplantations took place in 2021 for various organs such as kidneys, livers, and hearts in the United States include, 90,483, 11,891, 3,502, and 24,670, 9,236 and 3,817 respectively. Such a huge number of organ transplants that takes place in hospitals will therefore lead to increased adoption of HLA typing tests in the hospitals, thereby driving this segment growth.
In addition, rising initiatives by the hospitals for the conduction of camps and bone marrow donation programs will further drive the growth of this segment. For instance, in May 2022, on the occasion of World Thalassemia Day, Aster Hospitals held a stem-cell donor drive in collaboration with I Love To Care (India) Charitable Trust and DKMS-BMST Foundation India to increase awareness and provide hope for children with thalassemia. The drive was organized to encourage people to come forward and register as stem cell donors. Such initiatives will lead to increased adoption of HLA testing in hospitals to match the bone marrow of patients, driving this segment's growth.
Therefore, owing to the above-mentioned factors, the hospital segment is expected to register significant growth over the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to be a dominant region in the HLA Typing market, owing to the rising burden of genetic diseases and government initiatives to create awareness among people. According to the NIH in May 2022, it is estimated that the funding in the United States for organ transplantation was USD 208 million and USD 201 million in 2020 and 2021 respectively. The high funding for organ translation by the United States will lead to rising in the number of organ translations, thereby rising HLA typing adoption, and driving the market growth in this region. ,
Furthermore, according to the Organ Procurement and Transportation Network in January 2022, in the United States, 41,354 organ transplants were carried out in 2021, up 5.9 percent from the previous year and breaking the 40,000 mark for the first time. Such a high number of organ transplantations in developed countries will lead to increased adoption of the HLA typing market, driving the market growth over the forecast period.
In addition, the rising launch of HLA products by the key market players from the United States is also expected to drive market growth in this region. For instance, in March 2022, Immucor launched Mia Fora NGS Express HLA Typing Software. which gives users of Mia Fora NGS MFlex HLA Typing assays a faster and easier NGS analysis experience. Such type of HLA typing software will lead to increased adoption of HLA typing, thereby driving the market growth in this region.
Therefore, these above-mentioned factors are expected to fuel the growth of the HLA typing market in North America.
